OR WAIT null SECS
June 18, 2024
Yimmugo, which was introduced in Europe at the end of 2022, could be on the market in the US within months.
The research collaboration and licensing agreement will focus on the discovery and development of RNA exon editing therapeutics.
Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview.
June 17, 2024
Gabi Hanna, MD, CEO and co-founder of Lamassu Pharma talks about a novel oncology platform and the link between science and patient care.
June 14, 2024
Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.
Ecolab Life Sciences and Repligen have launched a new affinity resin, DurA Cycle, for large-scale biologics manufacturing.
June 13, 2024
Syngene's new production platform offers rapid protein synthesis with lower risk.
June 12, 2024
CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.
The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.
June 11, 2024
Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.
